Author

Yanan Yang

Observed names: Ya‐Nan Yang, Ya‑Nan Yang

Institutions: Army Medical University, Daping Hospital

Observed institutions: Mayo Clinic, Binzhou Medical University, Army Medical University, Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, Daping Hospital

OpenAlex ID: A5113903321

Roles of HOTAIR in lung cancer susceptibility and prognosis

2020 · Meng‐Meng Ren, Sen Xu, et al. · Molecular Genetics & Genomic Medicine · 40

High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients

2022 · Xingran Jiang, Xiang Zhou, et al. · Modern Pathology · 30

Correlation of PD ‐ L1 expression with CD8 + T cells and oxidative stress‐related molecules NRF2 and NQO1 in esophageal squamous cell carcinoma

2024 · Xin Zhang, Yanan Yang, et al. · The Journal of Pathology Clinical Research · 8

Anticancer roles of let‑7f‑1‑3p in non‑small cell lung cancer via direct targeting of integrin β1

2021 · Yanan Yang, Yuanrong Liu, et al. · Experimental and Therapeutic Medicine · 8

Effects of Chinese herbal medicine on the secondary prevention of chemotherapy-induced thrombocytopenia in malignant solid tumors, a randomized clinical trial

2025 · Yanan Yang, Weilin Ge, et al. · Phytomedicine · 6

Cisplatin decreases cyclin D2 expression via upregulating miR‑93 to inhibit lung adenocarcinoma cell growth

2019 · Ning Xie, Yuan‑Rong Liu, et al. · Molecular Medicine Reports · 5

Tumor marker-based RecistTM is superior to RECIST as criteria to predict the long-term benefits of targeted therapy in advanced non-small-cell lung cancer with driver gene mutations

2024 · Kai Xiong, Yi Yang, et al. · Neoplasia · 2

Abstract B07: Role of lysyl hydroxylases in metastatic lung cancer

2018 · Wei Liu, Ting Zhang, et al. · Cancer Research

Works count: 8

Citation count: 99

H-index: 5

I10-index: 2